Supplement encyclopedia

Silybum marianum

Milk thistle (Silybum marianum) is a plant whose fruits are used in various preparations and extracts.

Recheck the conclusions and consult the sources before choosing a supplement.

Main conclusion

What it may offer

  • Hot flashes are episodes of sudden heat. In one trial in women with menopausal symptoms, a specific milk thistle extract at 400 mg daily for eight weeks reduced hot flash frequency and severity more than placebo; the evidence remains preliminary.
  • In mothers of infants born before 32 weeks of gestation, BIO-C extract did not produce an additional increase in expressed milk over 28 days compared with placebo.
  • In a review of six studies, different silymarin-containing preparations did not convincingly reduce body weight compared with the control conditions. Participants included untrained men and people with type 2 diabetes or non-alcohol-related liver inflammation caused by fat accumulation.

[1] [2] [3] [4]

What was studied

  • One extract was tested for hot flash frequency and severity in women with menopausal symptoms.
  • Other research assessed expressed milk output in mothers of preterm infants. Weight was studied in mixed populations, including people with diabetes and liver disease.

[1] [2] [3] [4]

Which forms were considered

  • Milk thistle is a plant; silymarin is a mixture of substances in an extract, and silybin is one component of that mixture.
  • In the BIO-C study, 420 mg of dry extract contained 252 mg of micronized silymarin; when comparing labels, distinguish extract mass from silymarin content.

[1] [2] [3]

How to obtain it from food

  • Milk thistle leaves have historically been used in salads. This culinary use of the plant differs from taking a dry extract.
  • Roasted fruits have historically been used as a coffee substitute; their quantity does not determine the silymarin dose stated for an encapsulated extract.

[1] [2] [3]

Effects and studied questions

How to read the certainty scale 1–4

Certainty is rated separately for each outcome. 1 is very low, 2 is low, 3 is moderate and 4 is high.

Goal or questionResultConfidenceStudiesPopulation studiedKey sources
Hot flash frequencyIn one trial involving 80 women, milk thistle extract reduced hot flash frequency more than placebo. In the extract group, frequency fell from 4.32 to 1.31 per day; this is a within-group change, not the size of the advantage over placebo.In the extract group, frequency changed from 4.32±0.20 to 1.31±0.15 per day. The authors report a difference from placebo of p<0.001 at follow-up assessments; numerical placebo-group values and the between-group MD are not given in the available abstract.
1/4 Very lowPrecision of the estimate: the exact effect and CI are unavailable. Consistency of results: no grounds for a separate downgrade. Applicability to the specified group: the studied formulation and population; different scales. Possible publication bias: no specific data warrant a separate downgrade. Study methods: attrition and analysis have not been fully verified.
11 trialEvaluation of the effect of Silybum marianum extract on menopausal symptoms: A randomized, double-blind placebo-controlled trial ↗80 women with menopausal symptoms, 40 receiving extract and 40 receiving placebo
  1. Evaluation of the effect of Silybum marianum extract on menopausal symptoms: A randomized, double-blind placebo-controlled trial ↗
Hot flash severity according to the measure reported by the authorsIn the same trial, hot flash severity decreased more than with placebo. In the extract group, the published measure fell from 5.25 to 1.62; the exact between-group difference in changes is not given in the available abstract.The severity measure in the extract group changed from 5.25±0.22 to 1.62±0.08. The authors report a difference from placebo of p<0.001; the scale range and numerical between-group MD are not given in the abstract.
1/4 Very lowPrecision of the estimate: the exact effect and CI are unavailable. Consistency of results: no grounds for a separate downgrade. Applicability to the specified group: the studied formulation and population; different scales. Possible publication bias: no specific data warrant a separate downgrade. Study methods: attrition and analysis have not been fully verified.
11 trialEvaluation of the effect of Silybum marianum extract on menopausal symptoms: A randomized, double-blind placebo-controlled trial ↗80 women with menopausal symptoms, 40 receiving extract and 40 receiving placebo
  1. Evaluation of the effect of Silybum marianum extract on menopausal symptoms: A randomized, double-blind placebo-controlled trial ↗
Change in daily expressed milk mass, g/dayIn mothers of preterm infants, BIO-C did not produce an additional increase in expressed milk over 28 days: the difference in changes versus placebo was −52.4 g/day; the trial did not demonstrate an advantage for the supplement.Change of 24.9±38.1 with BIO-C versus 77.3±24.9 g/day with placebo; difference −52.4±45.5 g/day (mean±SE), one-sided superiority test p=0.872.
1/4 Very lowPrecision of the estimate: 50 participants; the exact contrast with CI was not extracted. Consistency of results: no grounds for a separate downgrade. Applicability to the specified group: a distinct population of mothers of preterm infants. Possible publication bias: no specific data warrant a separate downgrade. Study methods: attrition and measurement variability.
11 trialEvaluation of the galactogogue effect of silymarin on mothers of preterm newborns (<32 weeks) ↗50 mothers of infants born before 32 weeks: 25/25 randomized, 46 completed
  1. Evaluation of the galactogogue effect of silymarin on mothers of preterm newborns (<32 weeks) ↗

The study count refers to the cited source. Reviews with overlapping trials and outcomes from one study are not added together.

Daily intake requirements and upper limits

Intake and studied regimens
ContextInformation
Intake and studied regimensThe hot flash and lactation trials specify different preparations and amounts: 400 mg of extract/day and 420 mg of BIO-C extract/day, respectively. These are research regimens for a specific outcome, without a single dose applicable to all milk thistle products.

Evaluation of the effect of Silybum marianum extract on menopausal symptoms: A randomized, double-blind placebo-controlled trial ↗
Evaluation of the galactogogue effect of silymarin on mothers of preterm newborns (<32 weeks) ↗

Forms

Milk thistle, Silybum marianum, is a plant. Silymarin is a mixture of compounds in the extract; silybin is one of its components. These names do not denote the same composition and mass. Fruit powder, dry extract and silymarin are measured separately. In BIO-C, 420 mg of extract corresponded to 252 mg of micronized silymarin; 400 mg of extract from the hot flash trial cannot be considered 400 mg of silymarin.

Guidance for each goal

Hot flash frequency1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: the exact effect and CI are unavailable. Consistency of results: no grounds for a separate downgrade. Applicability to the specified group: the studied formulation and population; different scales. Possible publication bias: no specific data warrant a separate downgrade. Study methods: attrition and analysis have not been fully verified.

In one trial involving 80 women, milk thistle extract reduced hot flash frequency more than placebo. In the extract group, frequency fell from 4.32 to 1.31 per day; this is a within-group change, not the size of the advantage over placebo.

Study findings. In one trial involving 80 women, milk thistle extract reduced hot flash frequency more than placebo. In the extract group, frequency fell from 4.32 to 1.31 per day; this is a within-group change, not the size of the advantage over placebo.

Studied regimen400 mg of extract/dayOral Silybum marianum extract, Saberi 2020 study
Duration and population8 weeks of treatment and 4 weeks of follow-up; assessments at weeks 4, 8 and 1280 women with menopausal symptoms, 40 receiving extract and 40 receiving placebo

Comparison with Placebo capsules

Hot flash severity according to the measure reported by the authors1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: the exact effect and CI are unavailable. Consistency of results: no grounds for a separate downgrade. Applicability to the specified group: the studied formulation and population; different scales. Possible publication bias: no specific data warrant a separate downgrade. Study methods: attrition and analysis have not been fully verified.

In the same trial, hot flash severity decreased more than with placebo. In the extract group, the published measure fell from 5.25 to 1.62; the exact between-group difference in changes is not given in the available abstract.

Study findings. In the same trial, hot flash severity decreased more than with placebo. In the extract group, the published measure fell from 5.25 to 1.62; the exact between-group difference in changes is not given in the available abstract.

Studied regimen400 mg of extract/dayOral Silybum marianum extract, Saberi 2020 study
Duration and population8 weeks of treatment and 4 weeks of follow-up; assessments at weeks 4, 8 and 1280 women with menopausal symptoms, 40 receiving extract and 40 receiving placebo

Comparison with Placebo capsules

Change in daily expressed milk mass, g/day1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: 50 participants; the exact contrast with CI was not extracted. Consistency of results: no grounds for a separate downgrade. Applicability to the specified group: a distinct population of mothers of preterm infants. Possible publication bias: no specific data warrant a separate downgrade. Study methods: attrition and measurement variability.

In mothers of preterm infants, BIO-C did not produce an additional increase in expressed milk over 28 days: the difference in changes versus placebo was −52.4 g/day; the trial did not demonstrate an advantage for the supplement.

Study findings. In mothers of preterm infants, BIO-C did not produce an additional increase in expressed milk over 28 days: the difference in changes versus placebo was −52.4 g/day; the trial did not demonstrate an advantage for the supplement.

Studied regimen420 mg of dry extract/day, corresponding to 252 mg of micronized silymarin (BIO-C)BIO-C: dry Cardus Marianus L. extract, micronized silymarin
Duration and population28 days; primary outcome: mean of days 26–28 relative to baseline50 mothers of infants born before 32 weeks: 25/25 randomized, 46 completed

Comparison with Placebo

Change in body weight, kg1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: small sample, incomplete comparative estimates or a wide interval. Consistency of results: heterogeneous trials or a single study without confirmed replication. Applicability to the specified group: clinical populations, specific formulations or biomarkers limit generalization. Possible publication bias: not established; some meta-analyses retain possible grounds for concern. Study methods: small studies or incomplete reporting; limitations differ regarding subsequent analysis, attrition, control and multiple outcomes.

In a review of six studies with 325 participants, the studied silymarin-containing preparations did not convincingly reduce body weight: mean difference −0.69 kg (95% CI −1.69…+0.31).

Study findings. In a review of six studies with 325 participants, the studied silymarin-containing preparations did not convincingly reduce body weight: mean difference −0.69 kg (95% CI −1.69…+0.31).

Studied regimen140–2100 mg/day across six publications included in the weight analysisDifferent silymarin-containing preparations; some comparisons alongside exercise training or Berberis aristata
Duration and population4–48 weeks across weight studies325 participants in six studies in the review: untrained men, people with type 2 diabetes or NASH; nine comparative estimates

Comparison with Placebo, the same exercise training or a shared active treatment background, depending on the study

Safety and limitations

Oral use may cause bloating, nausea, gas and other gastrointestinal reactions. Allergy to milk thistle or other plants in the Asteraceae family is a contraindication for the fruit preparations described by EMA. Skin reactions and severe allergic reactions are possible; their frequency is unknown. Some supplements have shown discrepancies between their silymarin content and the label, and contamination with pesticides, microorganisms or mycotoxins. These findings concern the products tested, not the proportion of all products on the market. Safety data for milk thistle during pregnancy and breastfeeding are limited. The null lactation result for BIO-C does not establish the safety of every extract for mother and infant. In a 48-week Legalon trial in NASH, 44 of 78 participants reported adverse events, most often gastrointestinal; frequency did not differ significantly among the three groups (p=0.49). Two participants receiving 420 mg three times daily had their dose reduced or interrupted because of drug-related reactions; investigators considered four serious events unrelated.

Milk Thistle — NCCIH ↗ · Silybi mariani fructus — European Medicines Agency ↗ · Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial | PLOS One ↗

Interactions

WithEffectActionSource
Caffeine, tolbutamide, dextromethorphan and midazolam as probe drugsIn a 14-day study of one Legalon extract, no significant change in the tested CYP measures was found among 9 healthy volunteers who completed the study. This does not exclude interactions involving other products and medicines.If you take medicines, discuss a milk thistle supplement with your doctor or pharmacist.The Effects of Milk Thistle (Silybum marianum) on Human Cytochrome P450 Activity ↗
Milk Thistle — NCCIH ↗
WarfarinIn one report, INR rose from 2.64 to 4.12 while a milk thistle-containing product was taken and normalized after it was stopped. The full composition is unknown; a causal role for milk thistle alone has not been established.Before using the supplement, discuss it with the doctor managing your warfarin treatment and agree on INR monitoring.Milk Thistle | Memorial Sloan Kettering Cancer Center ↗

Food sources

The food descriptions concern plant parts: leaves and fruits. Silymarin is a mixture of substances in an extract, not the mass of these plant parts.

EMA describes comminuted fruits, powder, tea and milk thistle extracts as different forms. Results for the encapsulated extracts in this card apply to the studied preparations; they are not used to calculate an equivalent dose of tea or food powder.

Silybi mariani fructus — European Medicines Agency ↗

Leaves Milk thistle leaves have traditionally been used in salads.

Milk Thistle (PDQ®) — Health Professional Version ↗

Roasted fruits The plant's fruits have traditionally been roasted and used as a coffee substitute.

Milk Thistle (PDQ®) — Health Professional Version ↗

Powder and herbal tea The fruits are also used in comminuted and powdered forms and in herbal preparations for making tea. Their mass is not equivalent to the silymarin dose in an extract.

Silybi mariani fructus — European Medicines Agency ↗

Studies

PublicationWhat was studiedParticipantsForm and doseResult
Evaluation of the effect of Silybum marianum extract on menopausal symptoms: A randomized, double-blind placebo-controlled trial ↗randomized controlled trialHot flash frequency: Hot flash frequency Hot flash severity according to the measure reported by the authors: Hot flash severity according to the measure reported by the authorsHot flash frequency: 80 women with menopausal symptoms, 40 receiving extract and 40 receiving placebo Hot flash severity according to the measure reported by the authors: 80 women with menopausal symptoms, 40 receiving extract and 40 receiving placeboHot flash frequency: Oral Silybum marianum extract, Saberi 2020 study; 400 mg of extract/day; 8 weeks of treatment and 4 weeks of follow-up; assessments at weeks 4, 8 and 12; comparison: Placebo capsules Hot flash severity according to the measure reported by the authors: Oral Silybum marianum extract, Saberi 2020 study; 400 mg of extract/day; 8 weeks of treatment and 4 weeks of follow-up; assessments at weeks 4, 8 and 12; comparison: Placebo capsulesHot flash frequency: In one trial involving 80 women, milk thistle extract reduced hot flash frequency more than placebo. In the extract group, frequency fell from 4.32 to 1.31 per day; this is a within-group change, not the size of the advantage over placebo. Hot flash severity according to the measure reported by the authors: In the same trial, hot flash severity decreased more than with placebo. In the extract group, the published measure fell from 5.25 to 1.62; the exact between-group difference in changes is not given in the available abstract.
Evaluation of the galactogogue effect of silymarin on mothers of preterm newborns (<32 weeks) ↗randomized controlled trialChange in daily expressed milk mass, g/day50 mothers of infants born before 32 weeks: 25/25 randomized, 46 completedBIO-C: dry Cardus Marianus L. extract, micronized silymarin; 420 mg of dry extract/day, corresponding to 252 mg of micronized silymarin (BIO-C); 28 days; primary outcome: mean of days 26–28 relative to baseline; comparison: PlaceboIn mothers of preterm infants, BIO-C did not produce an additional increase in expressed milk over 28 days: the difference in changes versus placebo was −52.4 g/day; the trial did not demonstrate an advantage for the supplement.